Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 923 results for "sanofi"

Sanofi (SNY) Showing Bearish Technicals With Resistance At $46.72

Sanofi-Aventis (http://www.marketintelligencecenter.com/symbol/SNY"SNY) presents a trading opportunity that offers a 3.45% return in just 86 days. A covered call on Sanofi at the $45.00 level expiring on Mar. '15 offers an assigned return rate of ... Individual.com, 1 day ago

352 images for sanofi

Diabetes Mine, 3 days ago
Radio France Internationale, 1 week ago
SleekMoney, 1 week ago
Local Government Chronicle, 6 days ago
Reuters India, 1 week ago
KUSI.com, 1 week ago
Yahoo! Finance, 1 week ago
Mid Day, 3 days ago
BusinessWeek, 1 week ago
I Stock Analyst, 4 days ago

Potential Sanofi (SNY) Trade Has 4.42% Downside Protection

Sanofi-Aventis (http://www.marketintelligencecenter.com/symbol/SNY"SNY) traded between $45.57 and $46.40 before closing at $46.39 Friday and presents some attractive trading opportunities today. MarketIntelligenceCenter.comaEUR(TM)s patented ...
 Individual.com3 days ago Potential Sanofi (SNY) Trade Targets 3.78% Return  Individual.com2 days ago
Bio Spectrum Asia

Takeda taps Sanofi's top exec to lead global R

Singapore: Japan-based, Takeda pharmaceuticals has tapped Sanofi's executive, Mr Andrew Plump, to head global research and development of Sanofi. Mr Plump, the senior vice president for research and translational medicine at Sanofi will join ...
 Bio Spectrum Asia1 week ago Takeda appoints Sanofi's Andrew Plump to lead global R  Reuters1 week ago Takeda takes senior head from Sanofi  Pharmafocus1 week ago Sanofi's Plump tapped to head Takeda R&D from Cambridge base  FierceBiotech1 week ago
[x]  

Sanofi (SNY) Trading Near $47.03 Resistance Level

After closing Tuesday at $45.38, Sanofi-Aventis (http://www.marketintelligencecenter.com/symbol/SNY"SNY) presents an attractive opportunity to get a 4.70% return in just 93 days, which is an annualized return of 18.45% (for comparison purposes ...
 Individual.com1 week ago Sanofi (SNY) Showing Resistance Near $46.61  Individual.com1 week ago
Med India

MedidataVoice: Fighting Viral Epidemics: The Long Road To A Dengue Vaccine

Guest post by Kasia Hein-Peters, VP, Head of Marketing Dengue Vaccine, at Sanofi Pasteur. Dengue is currently the most common vector-borne virus disease and puts nearly half of the world at risk of this disease. Even though people living in Europe ...
 Austin American Statesman1 week ago Sanofi Pasteur's Adopt-a-Family Drive: 20 Years Strong!  Justmeans1 week ago Study: Universal dengue vaccine may be possible thanks to antibody discovery  FierceVaccines1 week ago Sanofi Pasteur's "Adopt-a-Family" Drive: 20 Years Strong!  Individual.com1 week ago
[x]  

Global Multiple Myeloma Drugs Market 2015-2019 with Celgene, J & J, Novartis, Onyx Pharmaceuticals, Sanofi & Takeda Pharmaceutical Dominating

Research and Markets (http://www.researchandmarkets.com/research/7qwb87/global_multiple) has announced the addition of the "Global Multiple Myeloma Drugs Market 2015-2019" report to their offering. The Global Multiple Myeloma Drugs market to grow at ...
 Individual.com1 week ago Research and Markets Adds Report: 'Insulin Resistance - Pipeline Review, H2 2014'  Individual.com2 days ago Insulin Resistance - Pipeline Review, H2 2014  Individual.com6 days ago Research and Markets: Malaria - Pipeline Review, H1 2014  CNBC1 week ago
[x]  

Takeda Names Sanofi's Plump as Head of Research

Takeda Pharmaceutical Co. (4502), Asia's biggest drugmaker, named Sanofi's Andrew Plump as the next head of research and development as the company pursues its search for new medicines. Plump, 49, senior vice president for research and ...
 BusinessWeek1 week ago Takeda Snatches Sanofi Exec To Lead Global R  BioSpace1 week ago Takeda Names Sanofi's Plump R&D Head as Yamada Retires  Washington Post1 week ago
[x]  

REG-SANOFI : Information concerning the total number of voting rights and shares

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l'Autorité des Marchés Financiers ...
 Reuters6 days ago
Business Times Singapore

Sanofi signs lease for 40,000 sq ft office space at South Beach

Singapore PHARMACEUTICAL group Sanofi has inked a lease for about 40,000 sq ft of office space at South Beach Tower, BT understands. Another tenant includes City Serviced Office, an offshoot of City Developments Ltd (CDL), which has a 50.1 per ...
 Business Times Singapore1 week ago
Reuters India

Sanofi buys two equine health products from Bayer

PARIS Dec 17 (Reuters) - Sanofi said on Wednesday that Merial, its animal health unit, had reached an agreement with Bayer HealthCare to buy two Bayer equine health products for an undisclosed amount. Legend/Hyonate is an injectable solution that ...
 Reuters UK1 week ago SANOFI : Merial acquires two major equine health products from Bayer  4 Traders1 week ago REG-SANOFI : Merial acquires two major equine health products from Bayer  Reuters1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less